Lung Cancer

TRAP1 is a predictive biomarker of platinum-based adjuvant chemotherapy benefits in patients with resected lung adenocarcinoma.

Feb 25, 2020

Platinum-based adjuvant chemotherapy after complete resection has become a standard treatment for patients with stage II to IIIA non-small cell lung cancer; however, not all patients exhibit survival ...

The Impact of COPD on Survival in Patients With NSCLC

Feb 16, 2020

Patients with non-small cell lung cancer, or NSCLC, who have preexisting COPD have shorter survival in early stages of lung cancer, according to findings of a study. Prior chronic bronchitis showed wo...

Smoking tied to worse outcomes after a stroke

Jan 14, 2020

By Lisa Rapaport People who smoke or have recently quit have higher odds of being severely impaired after a stroke than their counterparts who never smoked, a new study su...

CDC: Cases of Flu Continue to Mount Across America

Jan 07, 2020

Agency says it is still too early to know how severe this year's flu season will be. MONDAY, Dec. 30, 2019 (HealthDay News) -- Flu continues to spread throughout the United States and has reached...